{"adverse_reactions":["Sincerus Florida, LLC adverse reactions. d"],"components":["Active, inactive j"],"effective_time":"20190502","id":"87ed8125-8403-5d53-e053-2995a90a6516","instructions_for_use":["Directions for use h"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1065-2 DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL 30 gm c"],"set_id":"87ed8125-8402-5d53-e053-2995a90a6516","spl_product_data_elements":["DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% DAPSONE DAPSONE TRETINOIN TRETINOIN NIACINAMIDE NIACINAMIDE"],"version":"1"}